Resectable Hepatocellular Carcinoma
1 competing product in clinical development for Resectable Hepatocellular Carcinoma.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ateganosine + Cadonilimab | MAIA Biotechnology | Phase 1 | Recruiting | 25 |